Advent of PARP Inhibitors in Metastatic CRPC
Moving on to discuss metastatic castration-resistant prostate cancer, panelists highlight the evolving role of PARP inhibition in this setting.
Source: onclive.com
Stay updated with breaking news from Arsi Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moving on to discuss metastatic castration-resistant prostate cancer, panelists highlight the evolving role of PARP inhibition in this setting.